|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zuliani AC, Esteves SC, Teixeira LC,
Teixeira JC, de Souza GA and Sarian LO: Concomitant cisplatin plus
radiotherapy and high-dose-rate brachytherapy versus radiotherapy
alone for stage IIIB epidermoid cervical cancer: A randomized
controlled trial. J Clin Oncol. 32:542–547. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen S, Saiyin H, Zeng X, Xi J, Liu X, Li
X and Yu L: Isolation and functional analysis of human HMBOX1, a
homeobox containing protein with transcriptional repressor
activity. Cytogenet Genome Res. 114:131–136. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Déjardin J and Kingston RE: Purification
of proteins associated with specific genomic Loci. Cell.
136:175–186. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kappei D, Butter F, Benda C, Scheibe M,
Draškovič I, Stevense M, Novo CL, Basquin C, Araki M, Araki K, et
al: HOT1 is a mammalian direct telomere repeat-binding protein
contributing to telomerase recruitment. EMBO J. 32:1681–1701. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Feng X, Luo Z, Jiang S, Li F, Han X, Hu Y,
Wang D, Zhao Y, Ma W, Liu D, et al: The telomere-associated
homeobox-containing protein TAH1/HMBOX1 participates in telomere
maintenance in ALT cells. J Cell Sci. 126:3982–3989. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Palm W and de Lange T: How shelterin
protects mammalian telomeres. Annu Rev Genet. 42:301–334. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
de Lange T: Protection of mammalian
telomeres. Oncogene. 21:532–540. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Blackburn EH: Switching and signaling at
the telomere. Cell. 106:661–673. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
McIlrath J, Bouffler SD, Samper E,
Cuthbert A, Wojcik A, Szumiel I, Bryant PE, Riches AC, Thompson A,
Blasco MA, et al: Telomere length abnormalities in mammalian
radiosensitive cells. Cancer Res. 61:912–915. 2001.PubMed/NCBI
|
|
11
|
Mirjolet C, Boidot R, Saliques S,
Ghiringhelli F, Maingon P and Créhange G: The role of telomeres in
predicting individual radiosensitivity of patients with cancer in
the era of personalized radiotherapy. Cancer Treat Rev. 41:354–360.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang H, Wu L, Ke S, Wang W, Yang L, Gao X,
Fang H, Yu H, Zhong Y, Xie C, et al: Downregulation of
ubiquitin-conjugating enzyme UBE2D3 promotes telomere maintenance
and radioresistance of Eca-109 human esophageal carcinoma cells. J
Cancer. 7:1152–1162. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cawthon RM: Telomere measurement by
quantitative PCR. Nucleic Acids Res. 30:e472002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao X, Wang W, Yang H, Wu L, He Z, Zhou S,
Zhao H, Fu Z, Zhou F and Zhou Y: UBE2D3 gene overexpression
increases radiosensitivity of EC109 esophageal cancer cells in
vitro and in vivo. Oncotarget. 7:32543–32553. 2016.PubMed/NCBI
|
|
15
|
Franken NA, Rodermond HM, Stap J, Haveman
J and van Bree C: Clonogenic assay of cells in vitro. Nat Protoc.
1:2315–2319. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
d'Adda di Fagagna F, Reaper PM,
Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G,
Carter NP and Jackson SP: A DNA damage checkpoint response in
telomere-initiated senescence. Nature. 426:194–198. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Paull TT, Rogakou EP, Yamazaki V,
Kirchgessner CU, Gellert M and Bonner WM: A critical role for
histone H2AX in recruitment of repair factors to nuclear foci after
DNA damage. Curr Biol. 10:886–895. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shiloh Y: ATM and related protein kinases:
Safeguarding genome integrity. Nat Rev Cancer. 3:155–168. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Drissi R, Wu J, Hu Y, Bockhold C and Dome
JS: Telomere shortening alters the kinetics of the DNA damage
response after ionizing radiation in human cells. Cancer Prev Res.
4:1973–1981. 2011. View Article : Google Scholar
|
|
20
|
Yang L, Wang W, Hu L, Yang X, Zhong J, Li
Z, Yang H, Lei H, Yu H, Liao Z, et al: Telomere-binding protein
TPP1 modulates telomere homeostasis and confers radioresistance to
human colorectal cancer cells. PLoS One. 8:e810342013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tribius S, Pidel A and Casper D: ATM
protein expression correlates with radioresistance in primary
glioblastoma cells in culture. Int J Radiat Oncol Biol Phys.
50:511–523. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rainey MD, Charlton ME, Stanton RV and
Kastan MB: Transient inhibition of ATM kinase is sufficient to
enhance cellular sensitivity to ionizing radiation. Cancer Res.
68:7466–7474. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chang L, Graham PH, Hao J, Ni J, Bucci J,
Cozzi PJ, Kearsley JH and Li Y: PI3K/Akt/mTOR pathway inhibitors
enhance radiosensitivity in radioresistant prostate cancer cells
through inducing apoptosis, reducing autophagy, suppressing NHEJ
and HR repair pathways. Cell Death Dis. 5:e14372014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Alao JP and Sunnerhagen P: The ATM and ATR
inhibitors CGK733 and caffeine suppress cyclin D1 levels and
inhibit cell proliferation. Radiat Oncol. 4:512009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu WG, Seno JD, Beck BD and Dynlacht JR:
Translocation of MRE11 from the nucleus to the cytoplasm as a
mechanism of radiosensitization by heat. Radiat Res. 156:95–102.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Loayza D and De Lange T: POT1 as a
terminal transducer of TRF1 telomere length control. Nature.
423:1013–1018. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ma H, Su L, Yue H, Yin X, Zhao J, Zhang S,
Kung H, Xu Z and Miao J: HMBOX1 interacts with MT2A to regulate
autophagy and apoptosis in vascular endothelial cells. Sci Rep.
5:151212015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ribero S, Sanna M, Visconti A, Navarini A,
Aviv A, Glass D, Spector TD, Smith C, Simpson M, Barker J, et al:
Acne and telomere length: A new spectrum between senescence and
apoptosis pathways. J Invest Dermatol. 137:513–515. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Wang X, Flores ER, Yu J and Chang
S: Dysfunctional telomeres induce p53-dependent and independent
apoptosis to compromise cellular proliferation and inhibit tumor
formation. Aging Cell. 15:646–660. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mauceri HJ, Hanna NN, Beckett MA, Gorski
DH, Staba MJ, Stellato KA, Bigelow K, Heimann R, Gately S, Dhanabal
M, et al: Combined effects of angiostatin and ionizing radiation in
antitumour therapy. Nature. 394:287–291. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Garcia-Barros M, Paris F, Cordon-Cardo C,
Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z and Kolesnick R:
Tumor response to radiotherapy regulated by endothelial cell
apoptosis. Science. 300:1155–1159. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Meng MB, Jiang XD, Deng L, Na FF, He JZ,
Xue JX, Guo WH, Wen QL, Lan J, Mo XM, et al: Enhanced radioresponse
with a novel recombinant human endostatin protein via tumor
vasculature remodeling: Experimental and clinical evidence.
Radiother Oncol. 106:130–137. 2013. View Article : Google Scholar : PubMed/NCBI
|
